NLRP3 and atherosclerosis: Our data showed that mRNA levels of ABCA1 and ABCG1 were increased after the treatment of NLRP3i, suggesting that NLRP3 gene silencing could be a potentially therapeutic mean to increase macrophage cholesterol efflux for the prevention of atherosclerosis.